Prof. Akiko Iwasaki

@virusesimmunity.bsky.social

We study antiviral immunity and viral disease pathogenesis. We are developing mucosal vaccine strategies to prevent infection and transmission. #COVID19 #longCOVID #vaccines

Such an informative #LongCOVID ‘Questions and Answers’ presentation by Prof. Akiko Iwasaki, @virusesimmunity.bsky.social It’s so important to recognise the airborne nature of this dreadful disease and its implications, for us all, particularly those most vulnerable. www.youtube.com/watch?v=ilIO...

Long COVID 2025: Symptoms, diagnosis, post-COVID treatments and the latest long COVID research

YouTube video by American Medical Association (AMA)

youtube.com

@virusesimmunity.bsky.social, who studies long COVID and other post-viral conditions, says, “If we don’t figure this out now with this pandemic, I’m afraid we will be much less prepared for future pandemics.” These terminations have already hit @mclellanlab.bsky.social. More will come.

Jason McLellan@mclellanlab.bsky.social · last yr.

We just had our first grant terminated. This was a U19 AViDD grant (grants.nih.gov/grants/guide...). It was set to end next month, although many in the consortia were hoping for NCEs.

If you have long COVID and live near @coresinai.bsky.social, please consider participating in the clinical trial to test antiviral medications (Truvada, Seizentry). Yale Center for Infection and Immunity will be doing biomarker analysis. Please sign up here and spread the word 📣

Cohen Center for Recovery from Complex Chronic Illness@coresinai.bsky.social · 2y ago

Long COVID and viral reactivation are linked. Our latest trial focuses on repurposing existing, broad spectrum antivirals to reduce symptoms in adults with #LongCOVID. Our clinical trial is currently recruiting!

Looking forward to attending the 22nd Takeda Science Foundation Symposium on Bioscience in Osaka next week and catching up with immunology colleagues. 第22回武田科学振興財団生命科学シンポジウム-ヒト免疫系を解き明かす

Bild